2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 374.94

+0.2%

Nov 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

marcher

pak73

To: maceng2 who wrote (176994)	8/22/2021 3:30:49 PM
From: arun gera	2 Recommendations Read Replies (1) of 217882

<Are off the shelf, and generic, with a history of being safe.> So is aspirin. A lot more people use Aspirin compared to HCQ and Ivermectin. Why are you not crowing about Aspirin. medicalnewstoday.com After these adjustments, aspirin use was associated with a 43% reduced risk of intensive care unit admission, a 44% reduced risk of mechanical ventilation, and a 47% reduced risk of dying in the hospital. While there was no evidence that aspirin increased the risk of bleeding, the authors recommend caution: “Until a randomized controlled trial of aspirin is performed, it is imperative to exercise cautious optimism and deliberately balance aspirin’s known risks against its potential benefits in patients afflicted by COVID-19.” What about Listerine? news-medical.net The study, published in the journal Pathogens, found that Listerine and the prescription mouthwash Chlorhexidine disrupted the virus within seconds after being diluted to concentrations that would mimic actual use. Further studies are needed to test real-life efficacy in humans. What about Antacids? cuimc.columbia.edu We found an association between famotidine and improved outcomes in our analysis, but there could be unknown factors that we were unable to account for that might explain this finding,” Freedberg adds. “Whether famotidine is effective as a treatment for patients with COVID-19 is an open question and needs to be explored in a randomized clinical trial. As if they other generics were not investigated. But you are stuck on HCQ and Ivermectin. -Arun

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next